VARKI PAUL 4
4 · Avalo Therapeutics, Inc. · Filed Jun 25, 2024
Insider Transaction Report
Form 4
VARKI PAUL
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-24+150,000→ 150,000 totalExercise: $13.43Exp: 2034-06-24→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Option Shares vest on June 24, 2025 and the remainder of the Option Shares will vest in equal monthly installments on the first day of each month thereafter over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.